Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
公司代碼SLP
公司名稱Simulations Plus Inc
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)
員工數量212
證券類型Ordinary Share
年結日Jun 18
公司地址800 Park Offices Drive, Suite 401
城市RESEARCH TRIANGLE PARK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編27709
電話16617237723
網址https://www.simulations-plus.com/
公司代碼SLP
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)